Position in NVS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$8,116,371
+$3,153,051 QoQ
Shares Held
53,135
+47.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026China Universal Asset Management Co., Ltd. holds $79,455,338 across 14 Drug Manufacturers - General names. NVS ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
62,410 | $21,958,958 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
157,523 | $21,953,980 | |
| 3 | NVS |
Novartis AG
This page
|
53,135 | $8,116,371 | |
| 4 | JNJ |
Johnson & Johnson
|
28,460 | $6,956,762 | |
| 5 | AZN |
Astrazeneca PLC
|
25,600 | $5,048,832 | |
| 6 | BIIB |
Biogen Inc.
|
26,044 | $4,774,646 | |
| 7 | LLY |
ELI LILLY & Co
|
4,288 | $3,943,973 | |
| 8 | SNY |
Sanofi
|
43,433 | $2,092,601 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,116,371 | 53,135 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $4,963,320 | 36,000 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,564,800 | 20,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,815,150 | 15,000 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $1,250,805 | 11,220 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,091,818 | 11,220 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||